425: AlphaTime Extends SPAC Merger Deadline to April 2026

Sentiment:

Extension Approval


AlphaTime Acquisition Corp shareholders approved an extension to complete a business combination until April 4, 2026, with minimal redemptions.

Delay expectedThe company has extended its deadline to complete a business combination from January 4, 2026, to April 4, 2026.
Capital raiseThe sponsor will deposit $1 into the trust account for each monthly extension, up to three months, in exchange for a non-interest bearing, unsecured promissory note. This represents a form of capital contribution from the sponsor to facilitate the extension.

Summary

  • Shareholders of AlphaTime Acquisition Corp approved an extension for the company to complete a business combination.
  • The deadline has been extended from January 4, 2026, up to April 4, 2026, through three potential one-month extensions.
  • Each monthly extension requires a deposit of $1 into the trust account, in exchange for a non-interest bearing, unsecured promissory note payable upon business combination.
  • The extension was approved by shareholders via ordinary resolution for the Trust Agreement Amendment and special resolution for the Charter Amendment.
  • Only 69 ordinary shares were redeemed, representing approximately $854.22, or $12.38 per share.
  • Following redemptions, approximately $4,800,479.09 remains in the Trust Account.
  • The company now has 2,169,476 ordinary shares outstanding.

Sentiment

Score: 6

Explanation: The extension itself is neutral to slightly negative as it indicates a delay in finding a target. However, the very low redemption rate is a significant positive, preserving capital and indicating shareholder patience, which balances the overall sentiment to moderately positive.

Positives

  • Shareholders approved the extension, allowing the company more time to find and complete a business combination.
  • The number of redemptions was very low (69 shares), indicating strong shareholder support or low arbitrage interest, preserving most of the trust capital.
  • The trust account retains a substantial amount of funds ($4,800,479.09) after redemptions.

Negatives

  • The company has not yet identified or completed a business combination, necessitating an extension.
  • The extension requires additional payments into the trust account ($1 per month for up to three months), which, while small, represents a cost.
  • The promissory note issued for the extension payment is non-interest bearing and unsecured, meaning the sponsor bears some risk.

Risks

  • Failure to consummate a business combination by the extended deadline (April 4, 2026) would lead to the company ceasing operations and liquidating the trust account.
  • The company's ability to complete a business combination is subject to market conditions and the availability of suitable targets.
  • The company's public shareholders have the right to redeem their shares if certain amendments are made to the articles of association that modify redemption rights or the timeline for a business combination.

Future Outlook

The company now has an extended period until April 4, 2026, to identify and consummate a business combination. The management's focus will be on leveraging this additional time to secure a suitable target.

Management Comments

  • Although Proposal 3 [Adjournment Proposal] was approved, adjournment of the Meeting was not necessary or appropriate because the Company’s shareholders approved Proposal No. 1 to approve the Extension Amendment Proposal and Proposal No.2 to approve the Trust Agreement Amendment Proposal.

Industry Context

SPACs frequently seek extensions to their business combination deadlines, especially in challenging market conditions or when suitable targets are difficult to find. This extension by AlphaTime Acquisition Corp is consistent with a broader trend in the SPAC market where companies require more time to complete de-SPAC transactions. The low redemption rate, however, is somewhat positive compared to some SPACs that face high redemptions during extension votes.

Comparison to Industry Standards

  • The low redemption rate of 69 shares (representing a very small percentage of initial shares) is significantly lower than the average redemption rates seen in many SPAC extension votes, which often range from 50% to over 90%. This suggests either strong investor confidence in AlphaTime's ability to find a suitable target or a lack of arbitrageurs redeeming shares.
  • The extension payment of $1 per month is exceptionally low compared to typical SPAC extensions, which often involve sponsor contributions ranging from $0.03 to $0.10 per public share per month, or even fixed amounts in the tens of thousands. This minimal payment suggests a very low cost for the sponsor to extend, which could be viewed positively for the sponsor but might raise questions about the sponsor's commitment level if the actual cost is so negligible.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Articles of AssociationArticle 37.8 was amended to extend the deadline for consummating a Business Combination to April 4, 2026, allowing for up to three one-month extensions, each requiring additional funds from the Sponsor into the Trust Account.December 17, 2025Provides the company with more time to complete a business combination, but also outlines the liquidation process if a combination is not achieved by the new deadline.
Amendment to Articles of AssociationArticle 37.9 was amended to clarify redemption rights for public shareholders in the event of amendments to the articles that modify redemption substance or timing, or other provisions relating to public shareholder rights.December 17, 2025Ensures public shareholders retain specific redemption rights under certain amendment scenarios, protecting their interests.
Amendment to Articles of AssociationArticle 37.11 was amended to restrict the issuance of additional shares or securities that would entitle the holders thereof to receive funds from the Trust Account or vote as a class with public shares on a business combination or certain amendments, unless public shareholders are offered redemption.December 17, 2025Protects public shareholders from dilution or adverse changes to their voting/redemption rights prior to a business combination.
Amendment to Trust AgreementSection 1(i) of the Investment Management Trust Agreement was amended to reflect the extended deadline for a business combination and the procedures for liquidation of the Trust Account.December 16, 2025Aligns the trust agreement with the new extended timeline and clarifies liquidation procedures.

Related Party Transactions

  • The sponsor will deposit $1 for each monthly extension into the trust account in exchange for a non-interest bearing, unsecured promissory note, payable upon the consummation of a business combination. This is a transaction between the company and its sponsor.

Stakeholder Impact

  • Shareholders: Gain additional time for the company to find a suitable business combination, potentially increasing the likelihood of a successful de-SPAC transaction. Those who redeemed received $12.38 per share. Remaining shareholders continue to hold shares with the expectation of a future business combination.
  • Sponsor: Bears the cost of the extension payments ($1 per month) and the risk associated with the non-interest bearing, unsecured promissory note. Gains more time to complete their objective.
  • Creditors: The trust account funds are protected for public shareholders, with up to $100,000 of interest available for dissolution expenses in case of liquidation, subject to Cayman Islands law for creditor claims.

Next Steps

  • The company will continue to seek and evaluate potential business combination targets.
  • The sponsor will make monthly deposits of $1 into the trust account for each extension period utilized.
  • The company must consummate a business combination by April 4, 2026, or face liquidation.

Key Dates

DateDescription
December 30, 2022Original Investment Management Trust Agreement date.
December 28, 2023Date of Amendment No. 1 to the Original Trust Agreement and adoption of Third Amended and Restated Memorandum and Articles of Association.
December 20, 2024Date of Amendment No. 2 to the Original Trust Agreement.
September 9, 2025Date definitive proxy statement for Extension Amendment was filed with SEC.
October 1, 2025Date of Amendment No. 3 to the Original Trust Agreement.
December 16, 2025Date of Extraordinary General Meeting of shareholders where proposals were approved; date of entry into Trust Agreement Amendment.
December 17, 2025Date of amendment to the Company's Third Amended and Restated Memorandum and Articles of Association.
December 23, 2025Date of signing the Form 425 report.
January 4, 2026Original deadline to complete a business combination (Termination Date).
April 4, 2026New extended deadline to complete a business combination.

Recommendation

hold

The extension provides necessary time for AlphaTime to pursue a business combination, which is a positive for the SPAC's viability. The extremely low redemption rate indicates that a significant portion of the capital remains in the trust, which is favorable. However, the company still needs to secure a definitive business combination, which remains an inherent risk for any SPAC. Given the preserved capital and extended runway, holding the stock allows investors to await a potential target announcement without immediate downside from high redemptions, but the lack of a deal still presents uncertainty.

Keywords

SPAC, AlphaTime Acquisition Corp, business combination, extension, trust account, redemption, corporate governance, merger deadline, special purpose acquisition company, shareholder vote

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.